BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25757426)

  • 1. VHR/DUSP3 phosphatase: structure, function and regulation.
    Pavic K; Duan G; Köhn M
    FEBS J; 2015 May; 282(10):1871-90. PubMed ID: 25757426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DUSP3/VHR: A Druggable Dual Phosphatase for Human Diseases.
    Monteiro LF; Ferruzo PYM; Russo LC; Farias JO; Forti FL
    Rev Physiol Biochem Pharmacol; 2019; 176():1-35. PubMed ID: 30069819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined experimental and bioinformatics analysis for the prediction and identification of VHR/DUSP3 nuclear targets related to DNA damage and repair.
    Forti FL
    Integr Biol (Camb); 2015 Jan; 7(1):73-89. PubMed ID: 25375676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the roles of VHR/DUSP3 phosphatase in human diseases.
    Russo LC; Farias JO; Ferruzo PYM; Monteiro LF; Forti FL
    Clinics (Sao Paulo); 2018 Sep; 73(suppl 1):e466s. PubMed ID: 30208163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DUSP3/VHR is a pro-angiogenic atypical dual-specificity phosphatase.
    Amand M; Erpicum C; Bajou K; Cerignoli F; Blacher S; Martin M; Dequiedt F; Drion P; Singh P; Zurashvili T; Vandereyken M; Musumeci L; Mustelin T; Moutschen M; Gilles C; Noel A; Rahmouni S
    Mol Cancer; 2014 May; 13():108. PubMed ID: 24886454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.
    Arnoldussen YJ; Lorenzo PI; Pretorius ME; Waehre H; Risberg B; Maelandsmo GM; Danielsen HE; Saatcioglu F
    Cancer Res; 2008 Nov; 68(22):9255-64. PubMed ID: 19010898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic, cellular, and network analyses reveal new DUSP3 interactions with nucleolar proteins in HeLa cells.
    Panico K; Forti FL
    J Proteome Res; 2013 Dec; 12(12):5851-66. PubMed ID: 24245651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of DUSP3 activity radiosensitizes human tumor cell lines via attenuation of DNA repair pathways.
    Torres TEP; Russo LC; Santos A; Marques GR; Magalhaes YT; Tabassum S; Forti FL
    Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1879-1894. PubMed ID: 28389334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a potent inhibitor of human dual-specific phosphatase, VHR, from computer-aided and NMR-based screening to cellular effects.
    Shi Z; Tabassum S; Jiang W; Zhang J; Mathur S; Wu J; Shi Y
    Chembiochem; 2007 Nov; 8(17):2092-9. PubMed ID: 17933004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence.
    Rahmouni S; Cerignoli F; Alonso A; Tsutji T; Henkens R; Zhu C; Louis-dit-Sully C; Moutschen M; Jiang W; Mustelin T
    Nat Cell Biol; 2006 May; 8(5):524-31. PubMed ID: 16604064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A selective Seoul-Fluor-based bioprobe, SfBP, for vaccinia H1-related phosphatase--a dual-specific protein tyrosine phosphatase.
    Jeong MS; Kim E; Kang HJ; Choi EJ; Cho AR; Chung SJ; Park SB
    Chem Commun (Camb); 2012 Jul; 48(52):6553-5. PubMed ID: 22622190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinia H1-related phosphatase is a phosphatase of ErbB receptors and is down-regulated in non-small cell lung cancer.
    Wang JY; Yeh CL; Chou HC; Yang CH; Fu YN; Chen YT; Cheng HW; Huang CY; Liu HP; Huang SF; Chen YR
    J Biol Chem; 2011 Mar; 286(12):10177-84. PubMed ID: 21262974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced levels of Dusp3/Vhr phosphatase impair normal spindle bipolarity in an Erk1/2 activity-dependent manner.
    Tambe MB; Narvi E; Kallio M
    FEBS Lett; 2016 Aug; 590(16):2757-67. PubMed ID: 27423135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dusp3 deletion in mice promotes experimental lung tumour metastasis in a macrophage dependent manner.
    Vandereyken M; Jacques S; Van Overmeire E; Amand M; Rocks N; Delierneux C; Singh P; Singh M; Ghuysen C; Wathieu C; Zurashvili T; Sounni NE; Moutschen M; Gilles C; Oury C; Cataldo D; Van Ginderachter JA; Rahmouni S
    PLoS One; 2017; 12(10):e0185786. PubMed ID: 29020102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for the recognition of a bisphosphorylated MAP kinase peptide by human VHR protein Phosphatase.
    Schumacher MA; Todd JL; Rice AE; Tanner KG; Denu JM
    Biochemistry; 2002 Mar; 41(9):3009-17. PubMed ID: 11863439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of MAP kinases by the VHR dual-specific phosphatase: implications for cell growth and differentiation.
    Cerignoli F; Rahmouni S; Ronai Z; Mustelin T
    Cell Cycle; 2006 Oct; 5(19):2210-5. PubMed ID: 17012840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of dual-specificity phosphatase 3 in melanocytic oncogenesis.
    Chousakos E; Katsoulas N; Kavantzas N; Stratigos A; Lazaris AC
    Exp Dermatol; 2022 Oct; 31(10):1466-1476. PubMed ID: 35899430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unnatural amino acid mutagenesis reveals dimerization as a negative regulatory mechanism of VHR's phosphatase activity.
    Pavic K; Rios P; Dzeyk K; Koehler C; Lemke EA; Köhn M
    ACS Chem Biol; 2014 Jul; 9(7):1451-9. PubMed ID: 24798147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphotyrosine Substrate Sequence Motifs for Dual Specificity Phosphatases.
    Zhao BM; Keasey SL; Tropea JE; Lountos GT; Dyas BK; Cherry S; Raran-Kurussi S; Waugh DS; Ulrich RG
    PLoS One; 2015; 10(8):e0134984. PubMed ID: 26302245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine phosphorylation of VHR phosphatase by ZAP-70.
    Alonso A; Rahmouni S; Williams S; van Stipdonk M; Jaroszewski L; Godzik A; Abraham RT; Schoenberger SP; Mustelin T
    Nat Immunol; 2003 Jan; 4(1):44-8. PubMed ID: 12447358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.